Cargando…
Monitoring the Redox Status in Multiple Sclerosis
Worldwide, over 2.2 million people suffer from multiple sclerosis (MS), a multifactorial demyelinating disease of the central nervous system. MS is characterized by a wide range of motor, autonomic, and psychobehavioral symptoms, including depression, anxiety, and dementia. The blood, cerebrospinal...
Autores principales: | Tanaka, Masaru, Vécsei, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599550/ https://www.ncbi.nlm.nih.gov/pubmed/33053739 http://dx.doi.org/10.3390/biomedicines8100406 |
Ejemplares similares
-
Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis
por: Rajda, Cecilia, et al.
Publicado: (2017) -
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020) -
Proteomics in Multiple Sclerosis: The Perspective of the Clinician
por: Sandi, Dániel, et al.
Publicado: (2022) -
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
por: Rajda, Cecilia, et al.
Publicado: (2015) -
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
por: Tanaka, Masaru, et al.
Publicado: (2020)